PPP2CA
Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform
Also known as: PP2AA_HUMAN, PP2AC, PP2Calpha
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P67775
- Gene
- PPP2CA
- Ensembl
- ENSG00000113575
- Chromosome
- 5
- Canonical length
- 309 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes the phosphatase 2A catalytic subunit. Protein phosphatase 2A is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. This gene encodes an alpha isoform of the catalytic subunit. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
309 residues, UniProt reviewed canonical sequence.
>P67775|PPP2CA
1 MDEKVFTKEL DQWIEQLNEC KQLSESQVKS LCEKAKEILT KESNVQEVRC PVTVCGDVHG
61 QFHDLMELFR IGGKSPDTNY LFMGDYVDRG YYSVETVTLL VALKVRYRER ITILRGNHES
121 RQITQVYGFY DECLRKYGNA NVWKYFTDLF DYLPLTALVD GQIFCLHGGL SPSIDTLDHI
181 RALDRLQEVP HEGPMCDLLW SDPDDRGGWG ISPRGAGYTF GQDISETFNH ANGLTLVSRA
241 HQLVMEGYNW CHDRNVVTIF SAPNYCYRCG NQAAIMELDD TLKYSFLQFD PAPRRGEPHV
301 TRRTPDYFLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PPP2CA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 187 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 187 nTPM
- heart muscle: 156 nTPM
- thymus: 138 nTPM
- parathyroid gland: 128 nTPM
- tonsil: 127 nTPM
- cerebral cortex: 116 nTPM
Single-cell type
- tuft cells: 12 nCPM
- hepatic stellate cells: 6.5 nCPM
- megakaryocytes: 6.2 nCPM
- ocular epithelial cells: 5.2 nCPM
- erythrocyte progenitors: 4.8 nCPM
- megakaryocyte progenitors: 4.5 nCPM
Immune cell
- total PBMC: 158 nTPM
- myeloid DC: 130 nTPM
- eosinophil: 125 nTPM
- neutrophil: 122 nTPM
- NK-cell: 120 nTPM
- T-reg: 119 nTPM
Brain region
- cerebral cortex: 140 nTPM
- cerebellum: 122 nTPM
- hypothalamus: 115 nTPM
- white matter: 113 nTPM
- basal ganglia: 111 nTPM
- spinal cord: 110 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PPP2CA.
Disease | AllUniProt
Conditions PPP2CA is implicated in, by any mechanism.
- Houge-Janssens syndrome 3 (HJS3) MIM:618354
Disease | GeneticClinVar
42 pathogenic / likely-pathogenic of 277 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Houge-Janssens syndrome 3
- PPP2CA-related disorder
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 4.15
- DepMap mean gene effect
- -0.96
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular signal transduction
- meiotic cell cycle
- mesoderm development
- mitotic cell cycle
- negative regulation of canonical Wnt signaling pathway
- negative regulation of epithelial to mesenchymal transition
- negative regulation of glycolytic process through fructose-6-phosphate
- negative regulation of hippo signaling
- negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- peptidyl-threonine dephosphorylation
- positive regulation of NLRP3 inflammasome complex assembly
- protein dephosphorylation
- regulation of cell differentiation
- regulation of G1/S transition of mitotic cell cycle
- regulation of growth
- regulation of microtubule polymerization
- response to lead ion
- RNA polymerase II transcription initiation surveillance
- T cell homeostasis
- vascular endothelial cell response to oscillatory fluid shear stress
Molecular functions
- GABA receptor binding
- metal ion binding
- phosphoprotein phosphatase activity
- protein heterodimerization activity
- protein serine/threonine phosphatase activity
- protein tyrosine phosphatase activity
- RNA polymerase II CTD heptapeptide repeat S5 phosphatase activity
- tau protein binding
- RNA polymerase II CTD heptapeptide repeat S2 phosphatase activity
- RNA polymerase II CTD heptapeptide repeat S7 phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PPP2CA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PPP2CA as an antibody target. Whether an autoantibody or antibody against PPP2CA could matter depends on whether native PPP2CA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PPP2CA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PPP2CA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...